Across studies, the rate of sudden death in ibrutinib-treated patients ranged from 0.49 to 0.788 per 100 patient-years, roughly double that seen in comparators. In contrast, pooled analyses of ...
06/17/2025 Motion to expedite consideration of the petition for a writ of certiorari before judgment filed by petitioners Learning Resources, Inc., et al. 06/18/2025 Response to motion from ...
Forbes contributors publish independent expert analyses and insights. author of Chained to the Desk in a Hybrid World: A Guide to Balance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback